Medical experts discuss the LAUNCH study, EMERALD-1, and LEAP-012 trials, providing updates on the progress and findings that influence the treatment paradigm for hepatocellular carcinoma.
Updated Breast Cancer Screening Recommendations Pave the Way for a More Equitable Future
Breast Cancer Experts Share Obstacles and Successes as Women in Oncology
PROs Underscore Utility of Mirvetuximab Soravtansine in FRα+ Ovarian Cancer
FDA Approval Insights: NALIRIFOX in Metastatic Pancreatic Cancer
Personalized Dosimetry With Y-90 Glass Microspheres Shows Positive Activity in HCC
Iglesia Spotlights the Current Complexities of Treatment Sequencing in Advanced HCC
Vepdegestrant Plus Palbociclib Sustains Efficacy in Advanced ER+ Breast Cancer
Atezolizumab Plus Chemo Misses Mark in Early-Relapsing Unresectable TNBC
Olaparib/Durvalumab/Fulvestrant Combo Meets PFS End Point in HRR-Altered or MSI ER+/HER2– Breast Cancer
Frontline Atezolizumab Plus Sacituzumab Govitecan Elicits Responses in PD-L1+ Advanced TNBC